Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Vaccines against viral infections 

Vaccines against viral infections
Chapter:
Vaccines against viral infections
Author(s):

Janet E. McElhaney

DOI:
10.1093/med/9780198701590.003.0088
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 01 March 2021

A decline in immune function and increased susceptibility to infection is a hallmark of ageing. Influenza is foremost among these infections with 90% of deaths occurring in older adults despite widespread vaccination programmes. Common medical conditions and mental and psychosocial health issues, as well as degree of frailty and functional dependence may all contribute to the loss of immune responsiveness to infections and vaccination. The interactions of immune senescence, persistent cytomegalovirus infection, inflammaging (chronic elevation of inflammatory cytokines), and dysregulated cytokine production pose major challenges to the development of new or more effective vaccines. This chapter describes viral infections that have the greatest impact in older adults, age-related changes in the immune system that contribute to loss of vaccine responsiveness, available vaccines against influenza and herpes zoster and the need for vaccines against other viruses, and strategies for improving vaccine effectiveness to address the public health need for ‘vaccine preventable disability’.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.